SCHEMBL25907995

SCHEMBL25907995

CC(C)(C)OC(=O)N[C@@H](CCO)CCC(=O)OCc1ccccc1

nearest known ligand 0.56

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.56
ATM Q13315 1/20 0.50
PPARA Q07869 3/20 0.47
MAPT P10636 1/20 0.47
KLK7 P49862 1/20 0.46
KLK5 Q9Y337 1/20 0.46
CTSS P25774 4/20 0.45
CTSL P07711 2/20 0.45
CTSK P43235 3/20 0.44
ACE P12821 1/20 0.44
CTRB1 P17538 2/20 0.43
PPARG P37231 2/20 0.43
CTSB P07858 1/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
KMT2A Q03164 1/20 0.43
APP P05067 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3466396 0.92 SYK (0.57) SYKATMPPARAMAPTKLK7
SCHEMBL24298360 0.92 SYK (0.57) SYKATMPPARAMAPTKLK7
SCHEMBL3466395 0.92 SYK (0.57) SYKATMPPARAMAPTKLK7
SCHEMBL18976490 0.89 SYK (0.57) SYKATMPPARAMAPTKLK7
SCHEMBL31154007 0.89 SYK (0.57) SYKATMPPARAMAPTKLK7
SCHEMBL18575403 0.88 SYK (0.56) SYKATMPPARAMAPTKLK7
SCHEMBL17513638 0.88 SYK (0.56) SYKATMPPARAMAPTKLK7
SCHEMBL25318929 0.88 SYK (0.56) SYKATMPPARAMAPTKLK7
SCHEMBL8607451 0.87 SYK (0.55) SYKATMPPARAMAPTKLK7
SCHEMBL6776648 0.87 SYK (0.52) SYKATMPPARAMAPTKLK7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12459922-B2 PARP7 inhibitors GILEAD SCIENCES, INC. (US) 2025-11-04 US disclosed
EP-4469448-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. (US) 2024-12-04 EP disclosed
CN-118591537-A PARP7 inhibitors 吉利德科学公司 2024-09-03 CN disclosed
US-20230365529-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. 2023-11-16 US disclosed
US-20230365529-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. 2023-11-16 US disclosed
WO-2023147418-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. (US) 2023-08-03 WO disclosed
WO-2023147418-A1 PARP7 INHIBITORS GILEAD SCIENCES, INC. (US) 2023-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12459922-B2 PARP7 inhibitors PARP1, PARP11, PARP2 SYK 2284/4885ATM 206/4885PPARA 2003/4885
US-20230365529-A1 PARP7 INHIBITORS PARP1, PARP11, PARP2 SYK 2284/4885ATM 206/4885PPARA 2003/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.